The estimated Net Worth of Shauna L Vernal is at least $1.89 million dollars as of 23 January 2018. Shauna Vernal owns over 44,270 units of Innovator ETFs Trust stock worth over $291,100 and over the last 10 years Shauna sold INOV stock worth over $1,597,539.
Sign up
Shauna Vernal INOV stock SEC Form 4 insiders trading
Shauna has made over 6 trades of the Innovator ETFs Trust stock since 2015, according to the Form 4 filled with the SEC. Most recently Shauna sold 44,270 units of INOV stock worth $619,780 on 23 January 2018.
The largest trade Shauna's ever made was selling 44,270 units of Innovator ETFs Trust stock on 23 January 2018 worth over $619,780. On average, Shauna trades about 5,991 units every 56 days since 2015. As of 23 January 2018 Shauna still owns at least 10,000 units of Innovator ETFs Trust stock.
You can see the complete history of Shauna Vernal stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Shauna Vernal's mailing address?
Shauna's mailing address filed with the SEC is 4321, Collington Road, Essington, Bowie, Prince George's County, Maryland, 20716, United States.
Insiders trading at Innovator ETFs Trust
Over the last 10 years, insiders at Innovator ETFs Trust have traded over $17,222,256 worth of Innovator ETFs Trust stock and bought 1,096,675 units worth $14,934,745 . The most active insiders traders include Keith R Dunleavy, Christopher E Greiner et William D Green. On average, Innovator ETFs Trust executives and independent directors trade stock every 36 days with the average trade being worth of $987,207. The most recent stock trade was executed by William J Jr Teuber on 18 June 2021, trading 9,165 units of INOV stock currently worth $266,793.
What does Innovator ETFs Trust's logo look like?
Complete history of Shauna Vernal stock trades at Innovator ETFs Trust
Innovator ETFs Trust executives and stock owners
Innovator ETFs Trust executives and other stock owners filed with the SEC include:
-
Peter De Bock,
Chief Administrative Officer -
Jonathan Boldt,
Chief Financial Officer -
Jason Capitel,
Chief Operating Officer -
Robert Wychulis,
President -
Isaac Kohane,
Independent Director -
William Teuber,
Independent Director -
Lee Roberts,
Independent Director -
William Green,
Independent Director -
Denise Fletcher,
Independent Director -
Mark Pulido,
Non-Independent Director -
Dr. Keith R. Dunleavy,
Founder, Chairman & CEO -
Keith Dunleavy,
Chairman of the Board, Chief Executive Officer -
Andre Hoffmann,
Independent Director -
Dr. Paige C. Kilian M.D.,
Chief Medical Officer -
Ingrid E. Olsen,
Chief People Officer -
Kim E. Collins,
Sr. VP of Corp. Marketing & Communications -
Beverly Allen,
Gen. Counsel, Chief Compliance & Privacy Officer -
Hulus Alpay,
VP of Investor Relations -
Geoff Charron,
Chief Technology Officer -
June Duchesne,
Chief Legal Officer -
Shauna L Vernal,
Chief Legal Officer -
Joseph R Rostock,
Chief Technology Officer -
Daniel L Rizzo,
Chief Innovation Officer -
Thomas R Kloster,
Chief Financial Officer -
Christopher E Greiner,
Chief Product Officer & COO -
John Michael Burgin,
Chief Product Officer -
Eron Kelly,
President